免费观看成人毛片,91shipinzaixian,久久久久久免费播放一级毛片

證據(jù)文獻

NO	論文	登載期刊	PM ID	全文鏈接	中文鏈接
1	輔助免疫細胞療法與全身系統(tǒng)性療法結(jié)合治療實體瘤的療效	Anticancer Research 42: 4179-4187　/ 2022	35896218	https://ar.iiarjournals.org/content/42/8/4179	http://www.xingfuxuetang.com/laitian/results/22.html
2	食管癌對免疫細胞療法和低劑量納武單抗聯(lián)合治療有反應	Journal of Medical Case Reports 15, Article number: 191 / 2021	33827668	https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-020-02634-z	http://www.xingfuxuetang.com/laitian/results/23.html
3	免疫細胞療法治療晚期/復發(fā)性乳腺癌的預后因素	Anticancer Research 41:4133-4141 / 2021	34281884	https://ar.iiarjournals.org/content/41/8/4133.long	http://www.xingfuxuetang.com/laitian/results/1.html
4	過繼性T細胞免疫治療對晚期胰腺癌患者免疫學指標及預后的影響	CYTOTHERAPYFeb;23(2):137-145/2020	32907781	https://linkinghub.elsevier.com/retrieve/pii/S1465-3249(20)30813-6	http://www.xingfuxuetang.com/laitian/results/2.html
5	接受一線化療免疫治療的轉(zhuǎn)移性結(jié)直腸癌患者的免疫狀態(tài)變化	Anticancer Research 40:4763-4771 / 2020	32727803	https://ar.iiarjournals.org/content/40/8/4763.long	http://www.xingfuxuetang.com/laitian/results/3.html
6	過繼免疫細胞治療子宮頸神經(jīng)內(nèi)分泌癌	Anticancer Research 40:4741-4748 / 2020	32727800	https://ar.iiarjournals.org/content/40/8/4763	http://www.xingfuxuetang.com/laitian/results/4.html
7	免疫細胞治療子宮內(nèi)膜癌和宮頸癌預后因素的回顧性研究	Anticancer Research 40:4729-4740 / 2020	32727799	https://ar.iiarjournals.org/content/40/8/4729.long	http://www.xingfuxuetang.com/laitian/results/5.html
8	適應性免疫細胞治療對晚期胃癌患者免疫細胞譜的影響	Cancer Med 9(14):4907-4917 / 2020	32529780	https://ar.iiarjournals.org/content/40/8/4729.long	http://www.xingfuxuetang.com/laitian/results/6.html
9	γδT細胞免疫治療實體瘤預后因素的研究	CYTOTHERAPY Jun;22(6):329-336 / 2020	32303429	https://pubmed.ncbi.nlm.nih.gov/32303429/	http://www.xingfuxuetang.com/laitian/results/7.html
10	免疫細胞聯(lián)合一線化療治療結(jié)直腸癌的預后因素：一項回顧性研究	Anticancer Research 39: 4525-4532 / 2019	31366555	https://pubmed.ncbi.nlm.nih.gov/31366555/	http://www.xingfuxuetang.com/laitian/results/8.html
11	免疫細胞治療胰腺癌患者的預后因素	Anticancer Research 38 (7) 4353-4360 / 2018	29970573	https://pubmed.ncbi.nlm.nih.gov/29970573/	http://www.xingfuxuetang.com/laitian/results/9.html
12	腫瘤內(nèi)注射唑來膦酸鹽沖擊樹突狀細胞、靜脈過繼活化T淋巴細胞和吉西他濱聯(lián)合綜合免疫治療不可切除的局部晚期胰腺癌的I/II期臨床研究	Oncotarget Dec5;9(2):2838-2847./2017	29416816	https://pubmed.ncbi.nlm.nih.gov/29416816/	http://www.xingfuxuetang.com/laitian/results/10.html
13	全身靜脈過繼轉(zhuǎn)移自體淋巴因子激活的αβT細胞改善替莫唑胺誘導的膠質(zhì)瘤患者淋巴細胞減少	Anticancer Research Jul;37(7):3921-3932./2017	28668896	https://pubmed.ncbi.nlm.nih.gov/28668896/	http://www.xingfuxuetang.com/laitian/results/11.html
14	過繼免疫聯(lián)合化療治療IV期結(jié)直腸癌的臨床研究（COMVI研究）	Anticancer Research Jul;37(7):3941-3946. / 2017	28668898	https://pubmed.ncbi.nlm.nih.gov/28668898/	http://www.xingfuxuetang.com/laitian/results/12.html
15	過繼免疫細胞療法治療晚期胃癌的回顧性研究	Anticancer Research Jul;37(7):3947-3954. / 2017	28668899	https://pubmed.ncbi.nlm.nih.gov/28668899/	http://www.xingfuxuetang.com/laitian/results/13.html
16	mRNA-EP制備的腫瘤血管靶向CAR-T細胞用于臨床研究的免疫學質(zhì)量和性能	Mol Ther Oncolytics.Nov 16;3:16024. / 2016	27909701	https://pubmed.ncbi.nlm.nih.gov/27909701/	http://www.xingfuxuetang.com/laitian/results/14.html
17	活化αβT細胞過繼免疫化療治療IV期結(jié)直腸癌	Anticancer Research Jul;36(7):3741-6. / 2016	27354648	https://pubmed.ncbi.nlm.nih.gov/27354648/	http://www.xingfuxuetang.com/laitian/results/15.html
18	WT1抗原在多種實體癌細胞中表達的免疫組織化學分析	Anticancer Research 36(7):3715-3724 / 2016	27354645	https://pubmed.ncbi.nlm.nih.gov/27354645/	http://www.xingfuxuetang.com/laitian/results/16.html
19	自體免疫細胞治療改善不同類型晚期癌癥患者的免疫功能受損	Anticancer Research 36(7):3715-3724 / 2016	26168498	https://pubmed.ncbi.nlm.nih.gov/26168498/	http://www.xingfuxuetang.com/laitian/results/17.html
20	免疫細胞治療在不同類型晚期癌癥患者中的前瞻性安全性評價	Anticancer Research 35(8):4535-4543 / 2015	25075106	https://pubmed.ncbi.nlm.nih.gov/25075106/	http://www.xingfuxuetang.com/laitian/results/18.html
21	在晚期癌癥患者中評估細胞免疫狀態(tài)受損和失衡，并通過過繼性T細胞免疫治療恢復T細胞免疫狀態(tài)	International Immunopharmacology18(1):90-97. / 2014	24269583	https://pubmed.ncbi.nlm.nih.gov/24269583/	http://www.xingfuxuetang.com/laitian/results/19.html
22	封閉流式電穿孔系統(tǒng)治療實體瘤的自體腫瘤溶解物樹突狀細胞疫苗免疫治療	Anticancer Research 33(7):2971-6. / 2013	23780988	https://pubmed.ncbi.nlm.nih.gov/23780988/	http://www.xingfuxuetang.com/laitian/results/20.html
23	晚期肺癌過繼性活化T淋巴細胞免疫治療中觀察到的生存期延長：一項多中心歷史性隊列研究的結(jié)果	Cancer Immunology, Immunotherapy 61:1781-1790. / 2012	22422103	https://pubmed.ncbi.nlm.nih.gov/22422103/	http://www.xingfuxuetang.com/laitian/results/21.html